Bank of Montreal
EVFM

Bank of Montreal’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Bank of Montreal’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-760
Closed -$20K – 5384
2021
Q1 		$20K Hold
760
– – ﹤0.01% 4073
2020
Q4 		$31K Sell
760
-13
-2% -$470 ﹤0.01% 4214
2020
Q3 		$31K Buy
+773
New +$33.6K ﹤0.01% 3633

Other funds holding EVFM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of Montreal's EVFM Position: Q2 2022 in Review

Bank of Montreal sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 667 shares — an estimated $4K sold.

Bank of Montreal first reported a position in EVFM in Q3 2015 and held it in 10 quarters. The position peaked at $576K in Q2 2020. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

  • Bank of Montreal reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 667 Evofem Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $4K.
  • Bank of Montreal first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2015 and held it in 10 quarters.
  • Bank of Montreal's Evofem Biosciences, Inc. Common Stock position peaked at $576K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.